Sol-Millennium Medical Group
Amy Figlewski has extensive work experience in the healthcare industry. Amy is currently working as the Director of Acute Care Sales at SOL-MILLENNIUM Medical Group, where they are responsible for managing a comprehensive product portfolio of needles, syringes, and blood collection products. Amy has played a key role in securing a GPO contract with Premier for the company.
Prior to their current role, Amy worked at Owens & Minor for over 20 years, where they held various positions including Enterprise Director/VP Provider Services, Area Director, Account Executive, and Account Manager.
Before joining Owens & Minor, Amy worked at Charter Oak Consulting Group as a Project Manager. In this role, they assisted consultants in preparing for team building and management sessions, designed project manuals, and worked directly with clients.
Amy Figlewski earned their Bachelor of Science degree in Corporate Communications from Southern Connecticut State University. Amy pursued their education in this field from 1992 to 1996.
This person is not in any offices
Sol-Millennium Medical Group
We are one of the world's largest manufacturers of needles and syringes. We are vertically integrated with locations across the globe. Our innovative technology helps reduce unnecessary injuries, saves on medication and enhances both clinician and patient experience. Our international sales team is dedicated to delivering knowledge and outstanding customer service. Our goal is to partner with those in healthcare, focusing on a healthier tomorrow. Originally a leading producer of plastic moulds for the global medical industry - we were the first syringe mould producer in China and now supply over 60% of China’s syringe mould needs, as well exporting globally. This background sets the stage for our current focus in developing high quality and affordable safety medical devices that support best clinical practice – whilst also protecting healthcare workers (and their patients) from the risks associated with needlestick injury and accidental blood exposure. We currently manufacture a range of safety syringes, needles and blood collection devices under the Sol-Care and Sol-Guard brands. We also produce syringes and needles for the veterinary industry under the Sol-Vet line of products, as well as an extensive range of standard (non-safety) needles and syringes. We have a rich pipeline of new product innovation, and ambitious plans to grow our brands and our business. Close collaboration with frontline healthcare professionals is critical to the way we work – by sharing knowledge and ideas together we continuously improve our offer and work toward our goal of ‘Building a Heathier Tomorrow’. Sol Millennium has global presence with sales and marketing offices in Brazil, Poland and USA and a European R&D Centre, based in Switzerland.